Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec with Intensive Chemotherapy in Ph+ ALL
NCT00388895Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jun 2002
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Primary endpoints: Complete Response Rate, Feasibility of Glivec + Consolidation and 1 more. Started Jun 2002; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00388895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388895.